Free Newsletter
Major research grants headed to sequencing centers
The National Human Genome Research Institute has granted tens of millions of dollars to three major sequencing centers: The Broad Institute Sequencing Platform of the Massachusetts Institute of Technology and Harvard University; The Washington University Genome Sequencing Center, Washington University School of Medicine; and the Human Genome Sequencing Center, Baylor College of Medicine. They'll be assisting the Cancer Genome Atlas Pilot Project, which is attempting to systematically catalog the genetic causes of cancer.
Genomic sequencing has already made a substantial impact on both biological and medical research," said Dr. Francis Collins, NHGRI director. "A major focus of the next phase will be medical sequencing, which involves using sequencing technologies to identify genes that contribute to common human diseases, most of which have so far eluded gene hunters."
- here's the UPI report on the grants
Related Article:
New sequencing project in cancer. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




